| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $132K | -97.9% | -23.7% |
| R&D Expense | $5.9M | -9.2% | -25.3% |
| SG&A Expense | $6.8M | +39.0% | +22.4% |
| Operating Income | -$12.5M | -146.9% | +5.3% |
| Pre-tax Income | -$12.2M | -159.6% | +13.2% |
| Income Tax | $0 | — | — |
| Net Income | -$12.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.6M | -27.5% | +37.3% |
| Current Assets | $28.8M | -31.5% | -56.2% |
| Total Assets | $63.8M | -17.5% | -37.8% |
| Current Liabilities | $6.8M | -23.8% | -41.6% |
| Total Liabilities | $19.1M | -11.5% | -27.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.9M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $22.2M | — | — |
| Financing Cash Flow | $28K | — | — |
| Free Cash Flow | -$27.9M | — | — |
| +13.2% |
| $44.7M |
| -19.9% |
| -41.4% |